Keywords: USA, Medicare Part D, Congressional Budget Office, Generic substitution, Therapeutic substitution

Generic drugs in USA’s Medicare Part D saved beneficiaries and program $33 billion in 2007, says new CBO study

Article | 17 September 2010

New research released by the USA’s Congressional Budget Office (CBO) found that the use of generic medications rather ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in